PennyStocks101 Reports 3 TOP Stocks to Watch Closely: Gevo, Acadia Pharmaceuticals Inc., and Dryships Inc.

Beverly Hills, CA -- (SBWIRE) -- 03/21/2013 -- http://www.PennyStocks101.com - The US leader in microcap breakouts, offers a high quality stocks alert newsletter to investors looking for the best breakout stocks around. PennyStocks101 reports 3 penny stocks to keep an eye on for a possible bounce or more gains: GEVO, ACAD, and DRYS

The market fell on Thursday with major indexes lower at th eopen. The Dow Jones was down nearly 100 points, the S&P 500 was down five points, and the Nasdaq composite fell 20 points. Oracle made headlines for reporting a surprise decline in sales in its third quarter.

1. Gevo (Nasdaq: GEVO) - Gevo, Inc. is a renewable chemicals and advanced biofuels company engaged in the development of biobased alternatives to petroleum-based products using a combination of synthetic biology and chemistry.

2. Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) - Acadia Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders.

3. Dryships Inc. (Nasdaq: DRYS) - Dryships Inc., based in Greece, is an owner and operator of drybulk carriers that operate worldwide.

PennyStocks101.com educates and shows investors the inner workings of the volatile world of penny stocks by scouring the markets for the hottest penny stocks that look poised to break out. Discover the next hidden company to profit. Sign up for the free newsletter to receive the next big report soon. Join at: http://www.PennyStocks101.com

Sign Up at - http://www.PennyStocks101.com for more ideas to put on your radar.

Disclosure: PennyStocks101.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. This press release may contain several forward looking statements. Please read our report and visit our website for complete risks and disclosures.